Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI In Drug Repurposing Market, by Component
1.4.2 Europe AI In Drug Repurposing Market, by Technology
1.4.3 Europe AI In Drug Repurposing Market, by End Use
1.4.4 Europe AI In Drug Repurposing Market, by Application
1.4.5 Europe AI In Drug Repurposing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – Europe AI In Drug Repurposing Market
Chapter 5. State of Competition - Europe AI in Drug Repurposing market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. Europe AI In Drug Repurposing Market by Component
10.1 Europe Software & Platform Market by Country
10.2 Europe Services Market by Country
Chapter 11. Europe AI In Drug Repurposing Market by Technology
11.1 Europe Machine Learning/Deep Learning Market by Country
11.2 Europe Natural Language Processing (NLP) Market by Country
11.3 Europe Knowledge Graphs & Network-Based AI Market by Country
11.4 Europe Generative AI & Large Language Models (LLMs) Market by Country
11.5 Europe Computer Vision Market by Country
Chapter 12. Europe AI In Drug Repurposing Market by End Use
12.1 Europe Pharmaceutical & BioTechnology Companies Market by Country
12.2 Europe Contract Research Organizations (CROs) Market by Country
12.3 Europe Academic & Research Institutes Market by Country
12.4 Europe Other End Use Market by Country
Chapter 13. Europe AI In Drug Repurposing Market by Application
13.1 Europe Oncology Market by Country
13.2 Europe Neurology Market by Country
13.3 Europe Infectious Diseases Market by Country
13.4 Europe Rare & Orphan Diseases Market by Country
13.5 Europe Cardiology Market by Country
13.6 Europe Other Application Market by Country
Chapter 14. Europe AI In Drug Repurposing Market by Country
14.1 Germany AI In Drug Repurposing Market
14.1.1 Germany AI In Drug Repurposing Market by Component
14.1.2 Germany AI In Drug Repurposing Market by Technology
14.1.3 Germany AI In Drug Repurposing Market by End Use
14.1.4 Germany AI In Drug Repurposing Market by Application
14.2 UK AI In Drug Repurposing Market
14.2.1 UK AI In Drug Repurposing Market by Component
14.2.2 UK AI In Drug Repurposing Market by Technology
14.2.3 UK AI In Drug Repurposing Market by End Use
14.2.4 UK AI In Drug Repurposing Market by Application
14.3 France AI In Drug Repurposing Market
14.3.1 France AI In Drug Repurposing Market by Component
14.3.2 France AI In Drug Repurposing Market by Technology
14.3.3 France AI In Drug Repurposing Market by End Use
14.3.4 France AI In Drug Repurposing Market by Application
14.4 Russia AI In Drug Repurposing Market
14.4.1 Russia AI In Drug Repurposing Market by Component
14.4.2 Russia AI In Drug Repurposing Market by Technology
14.4.3 Russia AI In Drug Repurposing Market by End Use
14.4.4 Russia AI In Drug Repurposing Market by Application
14.5 Spain AI In Drug Repurposing Market
14.5.1 Spain AI In Drug Repurposing Market by Component
14.5.2 Spain AI In Drug Repurposing Market by Technology
14.5.3 Spain AI In Drug Repurposing Market by End Use
14.5.4 Spain AI In Drug Repurposing Market by Application
14.6 Italy AI In Drug Repurposing Market
14.6.1 Italy AI In Drug Repurposing Market by Component
14.6.2 Italy AI In Drug Repurposing Market by Technology
14.6.3 Italy AI In Drug Repurposing Market by End Use
14.6.4 Italy AI In Drug Repurposing Market by Application
14.7 Rest of Europe AI In Drug Repurposing Market
14.7.1 Rest of Europe AI In Drug Repurposing Market by Component
14.7.2 Rest of Europe AI In Drug Repurposing Market by Technology
14.7.3 Rest of Europe AI In Drug Repurposing Market by End Use
14.7.4 Rest of Europe AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
Unique Offerings 